Publications by authors named "Ram Murti Singh"
J Assoc Physicians India
December 2018
Article Synopsis
- The study evaluates the safety and efficacy of Arbekacin, an aminoglycoside antibiotic, in Indian patients with MRSA infections, as there's no prior published data for this group.
- The research involved a phase III trial with 162 patients randomized to receive either Arbekacin or Vancomycin, with the main goal of comparing overall cure rates between the two treatments.
- Results showed comparable cure rates (97.5% for Arbekacin and 100% for Vancomycin) and both antibiotics were well tolerated, suggesting Arbekacin could be a viable alternative to Vancomycin for treating MRSA infections.
